Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Betterlife Pharma Inc (BETR.CN)

Betterlife Pharma Inc (BETR.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 21,205
  • Shares Outstanding, K 84,822
  • Annual Sales, $ 0 K
  • Annual Income, $ -36,351 K
  • 60-Month Beta 2.04
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BETR.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -1.78
  • Most Recent Earnings -0.40 on 04/30/21
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

    TSX Bottom 100 Stocks

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.250 unch
on 09/20/21
0.350 -28.57%
on 09/09/21
-0.020 (-7.41%)
since 08/20/21
3-Month
0.230 +8.70%
on 07/09/21
0.365 -31.51%
on 07/27/21
-0.045 (-15.25%)
since 06/18/21
52-Week
0.230 +8.70%
on 07/09/21
2.270 -88.99%
on 01/04/21
-0.790 (-75.96%)
since 09/18/20

Most Recent Stories

More News
BetterLife Pharma Appoints Henri Sant-Cassia of The Conscious Fund to its Board of Directors

BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce that it has appointed Mr. Henri Sant-Cassia, co-founder...

BETR.CN : 0.250 (-9.09%)
BETRF : 0.2064 (-11.00%)
BetterLife Closes $6.325 Million Bought Deal Public Offering of Units, Including Full Exercise of the Over-Allotment Option

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

BETR.CN : 0.250 (-9.09%)
BETRF : 0.2064 (-11.00%)
BetterLife Announces $5.5 Million Bought-Deal Public Offering of Units

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

BETR.CN : 0.250 (-9.09%)
BetterLife Announces Closing of a Non-Brokered Private Placement

BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB : BETRF / FRA: NPAU) is pleased to announce that it has closed a non-brokered private placement (the "Offering") with one strategic...

BETR.CN : 0.250 (-9.09%)
BETRF : 0.2064 (-11.00%)
BetterLife Files Patent for Invention of Novel Subcutaneous Implant to Prevent Drug Diversion of LSD and Other Psychedelic Drugs

BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for...

BETR.CN : 0.250 (-9.09%)
BETRF : 0.2064 (-11.00%)
April Psychedelic Capital Investigates Clinical Trials & Real World Evidence & Going Mainstream: Mass Adoption

Toronto, Ontario--(Newsfile Corp. - April 28, 2021) - ("Microdose"), the leader in B2B psychedelic intelligence, in partnership with , the most active VC fund in the psychedelic space, is pleased to...

BETR.CN : 0.250 (-9.09%)
Former FDA Psychiatry Division Director Dr. Thomas Laughren Joins BetterLife as Regulatory Advisor

BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotechnology company developing second generation psychedelics for neuro-psychiatric disorders,...

BETR.CN : 0.250 (-9.09%)
BETRF : 0.2064 (-11.00%)
BetterLife Enters Into Research Agreement with UCSD for TD-0148A Behavioural Pharmacology Studies

VANCOUVER, BC / ACCESSWIRE / March 24, 2021 / BetterLife Pharma Inc. ("BetterLife" or the "Company") / / , an emerging biotech company focused on the development and commercialization of cutting-edge...

BETR.CN : 0.250 (-9.09%)
BETRF : 0.2064 (-11.00%)
Proactive news headlines including Altamira Gold, AIM ImmunoTech, QC Copper and Gold and Cloud Nine Education

- Altamira Gold Corp (CVE:ALTA) (OTCPINK:EQTRF) (FRA:T6UP) reveals four high-grade gold and silver vein structures at its Apiacas project in Brazil click here

ALTA : 39.86 (-0.85%)
EQTRF : 0.1633 (-13.55%)
ORGS : 4.92 (-3.15%)
QCCUF : 0.1800 (+28.57%)
AIM : 1.9800 (-2.94%)
ALPP : 2.2300 (-8.23%)
BETR.CN : 0.250 (-9.09%)
BETRF : 0.2064 (-11.00%)
CBDT.CN : 0.445 (-5.32%)
EPWCF : 0.3436 (-6.93%)
OGN : 32.94 (-3.20%)
EMRRF : 0.2801 (-3.41%)
CYRTF : 0.8501 (+0.16%)
BBR.CN : 0.140 (-6.67%)
NPEZF : 0.1159 (+2.57%)
KULR : 2.73 (+9.64%)
CYDY : 2.2600 (+12.44%)
TECX.CN : 0.415 (+2.47%)
TECXF : 0.3395 (-5.69%)
GBR : 3.74 (-7.88%)
GTBAF : 10.3700 (+0.48%)
CNI.CN : 0.350 (-10.26%)
CLGUF : 0.2731 (-10.90%)
AGRA.CN : 1.220 (+1.67%)
AGFAF : 0.0125 (+7.76%)
TCON : 3.78 (-0.53%)
Proactive news headlines including BetterLife Pharma, HempFusion Wellness, Pure Gold Mining, Mirasol Resources and OTC Markets Group

- Medexus Pharmaceuticals Inc (CVE:MDP) shares climb as Canaccord Genuity upgrades rating to Buy from Hold following fiscal 3Q results click here

MDP : 42.34 (+0.09%)
YAYO : 1.3000 (-3.70%)
MVMD.CN : 0.295 (-4.84%)
MVMDF : 0.2295 (-1.92%)
ALPP : 2.2300 (-8.23%)
MKVNF : 0.1560 (-14.29%)
BETR.CN : 0.250 (-9.09%)
BETRF : 0.2064 (-11.00%)
VLNCF : 1.8900 (-8.25%)
PHUN : 0.9900 (-5.71%)
AUSA.CN : 0.235 (-2.08%)
AUSAF : 0.1800 (-4.66%)
CBDHF : 0.2016 (-13.10%)
AGN.CN : 0.085 (-5.56%)
AGNPF : 0.0721 (-1.50%)
IP.CN : 0.120 (unch)
IPNFF : 0.0900 (-0.22%)
HLIX : 0.8400 (+9.09%)
PGM : 42.50 (-3.02%)
PUR.LN : 55.850 (+0.63%)
LRTNF : 0.7495 (-2.41%)
ASND : 157.61 (-2.41%)
ASDRF : 0.1847 (+8.01%)
THBRF : 3.4000 (-2.86%)
KTRA : 1.3000 (-7.14%)
CANN.CN : 0.070 (unch)
HERTF : 0.0589 (+5.18%)
MRZLF : 0.2836 (-0.14%)
OTCM : 45.5000 (-1.62%)
EXROF : 2.3100 (-4.15%)
CYRTF : 0.8501 (+0.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.308
2nd Resistance Point 0.297
1st Resistance Point 0.273
Last Price 0.250
1st Support Level 0.238
2nd Support Level 0.227
3rd Support Level 0.203

See More

52-Week High 2.270
Fibonacci 61.8% 1.491
Fibonacci 50% 1.250
Fibonacci 38.2% 1.009
Last Price 0.250
52-Week Low 0.230

See More

Business Summary

BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar